09-23-2021, 11:22 AM
NEW YORK — Pfizer Inc. has recalled its anti-smoking drug, Chantix, citing high concentrations of an ingredient linked to increased cancer risk.
In a notice posted to the U.S. Food and Drug Administration’s website on Thursday, Pfizer confirmed that it is recalling Chantix 0.5 mg and 1 mg tablets due to the presence of N-nitroso-varenicline.
In a notice posted to the U.S. Food and Drug Administration’s website on Thursday, Pfizer confirmed that it is recalling Chantix 0.5 mg and 1 mg tablets due to the presence of N-nitroso-varenicline.